CCEL Stock Summary and Trading Ideas (Cryo-Cell International | AMEX:CCEL)

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Cryo-Cell International trades on the AMEX stock market under the symbol CCEL.

As of April 10, 2026, CCEL stock price declined to $3.47 with 3,176 million shares trading.

CCEL has a market cap of $27.96 million. This is considered a Sub-Micro Cap stock.

Last quarter Cryo-Cell International reported $8 million in Revenue and -$.13 earnings per share. This beat revenue expectation by $143,166 and missed earnings estimates by -$.04.

In the last 3 years, CCEL traded as high as $9.50 and as low as $2.72.

The top ETF exchange traded funds that CCEL belongs to (by Net Assets): VTI, VXF, IWC.

CCEL has underperformed the market in the last year with a price return of -34.5% while the SPY ETF gained +30.9%. CCEL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -2.3% and +4.8%, respectively, while the SPY returned -1.8% and +7.2%, respectively.

CCEL support price is $3.48 and resistance is $3.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CCEL shares will trade within this expected range on the day.